Frontlight ResearchEarly access
Trial site
Brust-Zentrum Zürich
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Triple-negative breast cancer2 trials
- Metastatic breast cancer1 trial
- Phase
- Phase 32 trials
- Status
- Active, not recruiting2 trials
- Lead sponsor
- GBG Forschungs GmbH1 trial
- Gilead Sciences1 trial
Running trials
Active, not recruiting
Active, not recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Site data: ClinicalTrials.govUpdated 12 Nov 2026